Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS. (2008)

First Author: Kalmar B

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/j.1471-4159.2008.05595.x

PubMed Identifier: 18673445

Publication URI: http://europepmc.org/abstract/MED/18673445

Type: Journal Article/Review

Volume: 107

Parent Publication: Journal of neurochemistry

Issue: 2

ISSN: 0022-3042